Experience
Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*
Dr Reddy’s Laboratories (UK) Limited
Boehringer Ingelheim International GmbH
Successfully represented Boehringer Ingelheim to obtain interim injunction relief against Dr Reddy’s on patents covering the blockbuster medicine Jardiance® (empagliflozin) for treating type 2 diabetes mellitus, heart failure, and chronic kidney disease. This matter was named one of the “Top 20 Cases of 2026” by The Lawyer.
Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH, [2025] EWHC 2834 (Pat), Claim number: HP-2024-000037, Patents Court
Related Professionals
- Jin Ooi
- Partner
- London
- +44 20 7864 2821
Related Practices
Related Industries
*Matter handled prior to joining Finnegan.